Related Experiment Video
Updated: Oct 18, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
824
Immune Checkpoints in Cancers: From Signaling to the Clinic
Céline Pisibon1,2, Amira Ouertani1,2, Corine Bertolotto1,2
1Université Côte d'Azur, 06103 Nice, France.
Cancers
|September 28, 2021
Summary
Immune checkpoint inhibitors have transformed cancer treatment, but resistance remains a challenge. Understanding immune cell signaling is key to overcoming resistance and developing new immunotherapies.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Immune checkpoint inhibitors targeting CTLA4 and PD1 have revolutionized cancer therapy, particularly for melanoma.
- Despite significant benefits, many patients do not respond or develop resistance to these treatments.
- Deciphering immune checkpoint signaling is crucial for understanding and overcoming treatment resistance.
Purpose of the Study:
- To review the signaling pathways and cellular effects of various immune checkpoints.
- To discuss the biological and clinical relevance of immune checkpoints in different immune cells.
- To explore strategies for overcoming resistance and improving cancer immunotherapy.
Main Methods:
- Review of existing literature on immune checkpoint inhibitors and their mechanisms.
- Analysis of signaling pathways affecting T cells and other immune cells.
- Discussion of clinical outcomes and resistance mechanisms in cancer patients.
Main Results:
- Immune checkpoints modulate T cell functionality and coordination with other immune cells.
- Resistance to anti-PD1 therapy can be mediated by factors like ITGBL1 secreted by melanoma.
- Understanding the complex immune network is vital for enhancing immunotherapy efficacy.
Conclusions:
- Restoring T cell functionality and inter-immune cell coordination is necessary to overcome resistance.
- Future immunotherapies require consideration of the complex immune signaling network.
- Further research may uncover novel immune checkpoints for therapeutic targeting.
Related Concept Videos
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
01:19Interactions Between Signaling Pathways
6.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
01:27Tumor Immunotherapy
741
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
741
02:38Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
02:34Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K